Flaskdata.io CRO Partner Galilee CBR Achieves Faster Clinical Trials

Flaskdata.io, a technology company based in Israel, has announced that Galilee Clinical Bio Research, a boutique contract research organization (CRO) and one of the CRO partners of Flaskdata.io, has completed 5 clinical trials trials including a complex Phase 4 oncology study. The studies were conducted at more than 100 research sites in the USA and Israel.

Dr. Nadya Lisovoder, CEO of Galilee Clinical Bio Research, says, "The Flaskdata.io platform has executed direct data collection and automated monitoring of complex protocols. We have recently an ePRO system for challenging clinical and patient multi-cultural and multi-lingual conditions that support diverse patient populations in English, Russian, Hebrew and Arabic. The team provides fanatic service supporting research sites in Israel and the US."

Galilee Clinical Bio Research is currently initiating two Corona drug treatment studies on the Flaskdata.io platform with Corona patients who are being treated in three hospitals in Israel. Danny Lieberman, founder of Flaskdata.io, says, "We were delighted to win these new projects with Nadya and her team. This is further validation of the platform's capability to ramp-up and reduce trial execution times."

Flaskdata.io’s protocol automation compliance system utilizes a cloud platform to allow clients and partners to conduct data collection in real-time during clinical trials and take advantage of automated protocol compliance monitoring. One of the key elements of the platform is the Flask Data API. This API enables clients and partners utilizing connected medical devices for their clinical trials to collect data directly from such medical devices.

Patients who are part of the clinical trials have the capability to report their outcomes through the Flask Forms and all of the data that has been gathered can easily be tracked in real time through the Flask Data remote monitoring platform. The open Flask Data API can also be used to track patient compliance for wearable devices and non-compliance can be easily be noted by observing changes or non-changes in the patients’ vital signs.

Automated patient compliance monitoring is important because the usual manual method takes too long and serves as an obstacle to the success of the clinical studies. Also, patient compliance is essential for patient-centric clinical trials, home use devices, site-less trials, decentralized trials, and digital therapeutics.

The Flaskdata.io platform also makes use of AI automated playbook response to ensure high patient compliance reporting and to collect high quality risk signals from patients. Clients and partners can easily and quickly obtain an overview of the status of protocol compliance in the clinical trials at any time.

The Flask Data automation platform automates detection of protocol deviations and enables life science sponsors to reduce trial completion by 3-6 months.

Flaskdata provides a cloud platform for real-time clinical data collection and protocol monitoring automation that helps life science companies get interpretable data and save 3-6 months to study completion. For more information Contact Flaskdata.io.